Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. INmune Bio Inc shares valued at $36,350 were purchased by Juda Scott on Jun 25 ’24. At $7.27 per share, Juda Scott acquired 5,000 shares. The insider’s holdings grew to 71,603 shares worth approximately $0.56 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, Juda Scott purchased 7,000 shares, netting a total of over 48,650 in proceeds. Following the buying of shares at $6.95 each, the insider now holds 37,000 shares.
Before that, Schroeder Timothy j had sold 10,000 shares from its account. In a trade valued at $110,085, the Director traded INmune Bio Inc shares for $11.01 each. Upon closing the transaction, the insider’s holdings decreased to 10,000 shares, worth approximately $0.65 million.
As published in their initiating research note from Robert W. Baird on June 01, 2023, INmune Bio Inc [INMB] has been an Outperform and the price target has been revised to $16. Analysts at B. Riley Securities downgraded the stock from ‘”a Buy”‘ to ‘”a Neutral”‘ outlook in a report released in late May. As of July 07, 2021, Maxim Group has reiterated its “Buy” rating for INMB. Earlier on April 21, 2021, B. Riley Securities initiated its rating. Their recommendation was “a Buy” for INMB stock.
Analyzing INMB Stock Performance
During the last five days, there has been a surge of approximately 7.68%. Over the course of the year, INmune Bio Inc shares have dropped approximately -30.28%. Shares of the company reached a 52-week high of $14.74 on 02/14/24 and a 52-week low of $7.07 on 06/25/24. A 50-day SMA is recorded $9.69, while a 200-day SMA reached $9.91. Nevertheless, trading volume fell to 0.11 million shares from 0.2 million shares the previous day.
Support And Resistance Levels for INmune Bio Inc (INMB)
According to the 24-hour chart, there is a support level at 7.79, which, if violated, would cause prices to drop to 7.59. In the upper region, resistance lies at 8.20. The next price resistance is at 8.40. RSI (Relative Strength Index) is 41.12 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 0.12, which suggests the price will decrease in the coming days. Percent R is at 55.56%, indicating low price movement. Stochastics%K at holding indicates that the stock is to be held.
